The study covers the period of 2015-2019 in Germany, before approvals for CAR T-cell therapy, pirtobrutinib, and the arrival ...

The big question in administration of bispecific antibodies these days is how quickly they can move to the outpatient setting ...

Recent updates to the National Comprehensive Cancer Network (NCCN) guidelines for cutaneous squamous cell carcinoma (CSCC) ...

Dermoscopy can noninvasively identify immune checkpoint inhibitor (ICI)–related skin toxicities early in patients with ...

The study covers the period of 2015-2019, before approvals for CAR T-cell therapy, pirtobrutinib, and the arrival of covalent ...

As oral peptide therapies gain attention across metabolic health, sports performance, and longevity medicine, questions ...

Tyrosine kinase inhibitors (TKIs) lead to similar outcomes across racial and ethnic groups when used to treat acute myeloid ...

Linda Stein Gold, MD, shares recent findings from the pooled phase 3 analysis of the ADORING 1 and ADORING 2 trials for ...

James Song, MD, discusses the direction teledermatology is heading and how more inclusive clinical trials can improve ...

Between 4.9 million and 10.1 million people enrolled in Medicaid expansion are projected to lose coverage in 2028 under the ...

A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...

Mobile screening for kidney disease may be a valuable tool in improving population health and identifying at-risk patients, ...